Dr. Mary Scanlon, DO

NPI: 1245240548
Total Payments
$1,593
2024 Payments
$67.82
Companies
27
Transactions
92
Medicare Patients
2,299
Medicare Billing
$211,044

Payment Breakdown by Category

Food & Beverage$1,532 (96.2%)
Education$61.00 (3.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,532 91 96.2%
Education $61.00 1 3.8%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $323.77 20 $0 (2024)
Supernus Pharmaceuticals, Inc. $251.66 13 $0 (2023)
Astellas Pharma US Inc $134.57 6 $0 (2023)
Novo Nordisk Inc $116.35 7 $0 (2022)
Merck Sharp & Dohme LLC $102.08 6 $0 (2023)
PFIZER INC. $67.80 4 $0 (2021)
AstraZeneca Pharmaceuticals LP $65.03 4 $0 (2024)
EISAI INC. $59.22 4 $0 (2022)
Orexo US, Inc. $47.43 3 $0 (2021)
Allergan, Inc. $45.56 3 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $67.82 4 AstraZeneca Pharmaceuticals LP ($36.15)
2023 $318.99 14 AbbVie Inc. ($81.76)
2022 $441.78 23 Supernus Pharmaceuticals, Inc. ($160.04)
2021 $446.73 29 AbbVie Inc. ($165.99)
2020 $85.88 6 Allergan, Inc. ($45.56)
2019 $76.90 5 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($16.94)
2018 $67.62 5 Astellas Pharma US Inc ($29.84)
2017 $86.93 6 Astellas Pharma US Inc ($28.66)

All Payment Transactions

92 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
10/17/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $15.74 General
Category: PSYCHIATRY
10/03/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.94 General
Category: Cardiovascular and Metabolism
02/29/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $22.21 General
Category: Respiratory
01/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.93 General
Category: NEUROSCIENCE
11/02/2023 Abbott Laboratories FREESTYLE LIBRE 2 (Device) Food and Beverage In-kind items and services $21.89 General
Category: Diabetes Care
10/19/2023 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $20.99 General
Category: NEUROSCIENCE
07/27/2023 Astellas Pharma US Inc Education In-kind items and services $61.00 General
07/27/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $15.07 General
Category: Biological
07/06/2023 Merck Sharp & Dohme LLC BELSOMRA (Drug) Food and Beverage In-kind items and services $21.12 General
Category: NEUROSCIENCE
06/28/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.79 General
Category: RESPIRATORY
06/08/2023 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $27.83 General
Category: NEUROSCIENCE
04/03/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $18.28 General
Category: PSYCHOLOGY
03/09/2023 Merck Sharp & Dohme LLC STEGLATRO (Drug), BELSOMRA Food and Beverage In-kind items and services $17.45 General
Category: ENDOCRINOLOGY
02/09/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.14 General
Category: NEUROSCIENCE
02/08/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $21.42 General
Category: PSYCHOLOGY
02/02/2023 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $15.80 General
Category: NEUROSCIENCE
01/25/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $22.38 General
Category: PSYCHOLOGY
01/12/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $22.83 General
Category: INSOMNIA
12/15/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $17.23 General
Category: PSYCHOLOGY
11/22/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $22.01 General
Category: PSYCHOLOGY
11/09/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $20.90 General
Category: PSYCHOLOGY
10/14/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $24.11 General
Category: PSYCHOLOGY
10/13/2022 Kowa Pharmaceuticals America, Inc. Livalo (Drug), Seglentis Food and Beverage Cash or cash equivalent $15.84 General
Category: Cardiovascular
09/15/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $17.72 General
Category: PSYCHOLOGY
09/15/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $16.47 General
Category: PSYCHOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 775 912 $94,935 $63,710
2022 9 574 689 $78,295 $52,386
2021 11 572 710 $82,062 $54,805
2020 8 378 485 $65,830 $40,143
Total Patients
2,299
Total Services
2,796
Medicare Billing
$211,044
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 148 148 $29,600 $19,345 65.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 82 100 $13,015 $9,104 69.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 104 157 $14,155 $8,811 62.2%
99497 Advance care planning, first 30 minutes Office 2023 118 120 $10,200 $7,858 77.0%
99496 Transitional care management services for problem of high complexity Office 2023 28 37 $9,250 $7,075 76.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 34 38 $7,030 $4,969 70.7%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 27 67 $5,040 $2,657 52.7%
G0442 Annual alcohol misuse screening, 5 to 15 minutes Office 2023 90 90 $2,250 $1,667 74.1%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 86 86 $2,150 $1,593 74.1%
36415 Insertion of needle into vein for collection of blood sample Office 2023 38 47 $705.00 $394.80 56.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 20 22 $1,540 $237.20 15.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 119 119 $23,800 $15,932 66.9%
99497 Advance care planning, first 30 minutes Office 2022 158 158 $13,430 $10,016 74.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 77 102 $13,260 $9,259 69.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 93 147 $13,230 $8,127 61.4%
99496 Transitional care management services for problem of high complexity Office 2022 27 27 $6,750 $5,151 76.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 18 21 $3,950 $2,633 66.7%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2022 15 22 $1,655 $870.28 52.6%
36415 Insertion of needle into vein for collection of blood sample Office 2022 55 78 $1,170 $230.67 19.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 12 15 $1,050 $167.50 16.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 147 147 $29,400 $20,227 68.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 83 156 $14,040 $10,158 72.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 95 117 $15,210 $8,346 54.9%
99496 Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge Office 2021 24 32 $8,000 $6,400 80.0%
99497 Advance care planning by the physician or other qualified health care professional, first 30 minutes Office 2021 57 57 $4,845 $3,531 72.9%

About Dr. Mary Scanlon, DO

Dr. Mary Scanlon, DO is a Family Medicine healthcare provider based in Lake Worth, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245240548.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Scanlon, DO has received a total of $1,593 in payments from pharmaceutical and medical device companies, with $67.82 received in 2024. These payments were reported across 92 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,532).

As a Medicare-enrolled provider, Scanlon has provided services to 2,299 Medicare beneficiaries, totaling 2,796 services with total Medicare billing of $211,044. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Lake Worth, FL
  • Active Since 08/09/2006
  • Last Updated 05/04/2009
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1245240548

Products in Payments

  • QELBREE (Drug) $222.12
  • UBRELVY (Drug) $193.11
  • VRAYLAR (Drug) $110.97
  • BELSOMRA (Drug) $73.58
  • Ozempic (Drug) $70.70
  • QULIPTA (Drug) $65.25
  • Dayvigo (Drug) $59.22
  • Zubsolv (Drug) $47.43
  • NURTEC ODT (Drug) $43.65
  • FARXIGA (Drug) $42.82
  • ADHANSIA XR (Drug) $31.89
  • TRELEGY ELLIPTA (Drug) $31.81
  • MYRBETRIQ (Drug) $29.84
  • TROKENDI XR (Drug) $29.54
  • Myrbetriq (Drug) $28.66
  • XARELTO (Drug) $26.24
  • CHANTIX (Drug) $26.21
  • ABILIFY MAINTENA (Drug) $23.45
  • ELIQUIS (Drug) $23.04
  • QUVIVIQ (Drug) $22.83

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Lake Worth